A detailed history of Ggm Financials LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ggm Financials LLC holds 264 shares of REGN stock, worth $218,702. This represents 0.24% of its overall portfolio holdings.

Number of Shares
264
Previous 264 -0.0%
Holding current value
$218,702
Previous $277 Million 0.02%
% of portfolio
0.24%
Previous 0.26%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$883.2 - $1071.19 $233,164 - $282,794
264 New
264 $277 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $88.8B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Ggm Financials LLC Portfolio

Follow Ggm Financials LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ggm Financials LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ggm Financials LLC with notifications on news.